Literature DB >> 17620484

Damage to lipids, proteins, DNA, and RNA in mild cognitive impairment.

William R Markesbery1, Mark A Lovell.   

Abstract

Free radical-mediated oxidative damage is thought to play a role in the pathogenesis of Alzheimer disease. Previous studies have shown oxidative damage to lipids, proteins, DNA, and RNA in multiple brain regions in late-stage Alzheimer disease. Recent studies on patients with amnestic mild cognitive impairment who have undergone autopsy have shown increased lipid peroxidation as well as protein, DNA, and RNA oxidation in multiple brain regions. These studies establish oxidative damage as an early event in the pathogenesis of Alzheimer disease that can serve as a therapeutic target to slow the progression or perhaps the onset of the disease.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17620484     DOI: 10.1001/archneur.64.7.954

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  57 in total

1.  RNA oxidation catalyzed by cytochrome c leads to its depurination and cross-linking, which may facilitate cytochrome c release from mitochondria.

Authors:  Mikiei Tanaka; Pawel Jaruga; Pascal A Küpfer; Christian J Leumann; Miral Dizdaroglu; William E Sonntag; P Boon Chock
Journal:  Free Radic Biol Med       Date:  2012-06-07       Impact factor: 7.376

2.  Oxidative modification to LDL receptor-related protein 1 in hippocampus from subjects with Alzheimer disease: implications for Aβ accumulation in AD brain.

Authors:  Joshua B Owen; Rukhsana Sultana; Christopher D Aluise; Michelle A Erickson; Tulin O Price; Guojun Bu; William A Banks; D Allan Butterfield
Journal:  Free Radic Biol Med       Date:  2010-10-07       Impact factor: 7.376

Review 3.  Therapies targeting lipid peroxidation in traumatic brain injury.

Authors:  Tamil Selvan Anthonymuthu; Elizabeth Megan Kenny; Hülya Bayır
Journal:  Brain Res       Date:  2016-02-10       Impact factor: 3.252

4.  The effect of antioxidant vitamins E and C on cognitive performance of the elderly with mild cognitive impairment in Isfahan, Iran: a double-blind, randomized, placebo-controlled trial.

Authors:  A M Alavi Naeini; I Elmadfa; A Djazayery; M Barekatain; M R Aghaye Ghazvini; M Djalali; A Feizi
Journal:  Eur J Nutr       Date:  2013-12-11       Impact factor: 5.614

5.  Effects of the AMPA receptor modulator S 18986 on measures of cognition and oxidative stress in aged rats.

Authors:  S J Kelly; K Bernard; C Muñoz; R C Lawrence; J Thacker; C A Grillo; G G Piroli; L P Reagan
Journal:  Psychopharmacology (Berl)       Date:  2008-09-02       Impact factor: 4.530

6.  Inhibitory effect of some tropical green leafy vegetables on key enzymes linked to Alzheimer's disease and some pro-oxidant induced lipid peroxidation in rats' brain.

Authors:  Ganiyu Oboh; Ayodele Jacobson Akinyemi; Adedayo Oluwaseun Ademiluyi; Fatai Olumide Bello
Journal:  J Food Sci Technol       Date:  2011-11-04       Impact factor: 2.701

Review 7.  Antioxidants in central nervous system diseases: preclinical promise and translational challenges.

Authors:  Chandrashekhar D Kamat; Sunyana Gadal; Molina Mhatre; Kelly S Williamson; Quentin N Pye; Kenneth Hensley
Journal:  J Alzheimers Dis       Date:  2008-11       Impact factor: 4.472

8.  Oxidative stress in the progression of Alzheimer disease in the frontal cortex.

Authors:  Mubeen A Ansari; Stephen W Scheff
Journal:  J Neuropathol Exp Neurol       Date:  2010-02       Impact factor: 3.685

Review 9.  Mitochondrial abnormalities in Alzheimer's disease: possible targets for therapeutic intervention.

Authors:  Diana F Silva; J Eva Selfridge; Jianghua Lu; Lezi E; Sandra M Cardoso; Russell H Swerdlow
Journal:  Adv Pharmacol       Date:  2012

Review 10.  Multifunctional roles of enolase in Alzheimer's disease brain: beyond altered glucose metabolism.

Authors:  D Allan Butterfield; Miranda L Bader Lange
Journal:  J Neurochem       Date:  2009-09-23       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.